Drug Profile
Research programme: nonsteroidal anti-inflammatory drugs topical - Avecho Biotechnology
Alternative Names: NSAID/TPM®; TPM®/Ibuprofen Gel; TPM®/NSAIDLatest Information Update: 28 Nov 2020
Price :
$50
*
At a glance
- Originator Phosphagenics
- Developer Avecho Biotechnology
- Class Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for preclinical development in Pain in Australia (Topical, Gel)
- 25 Oct 2016 Preclinical trials in Pain in Australia (Topical) (Phosphagenics pipeline, October 2016)
- 17 Mar 2014 Early research in Pain in Australia (Topical)